메뉴 건너뛰기




Volumn 47, Issue 3, 1998, Pages 250-256

Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; GLUCOSE; NEUTRAL INSULIN; PLACEBO;

EID: 0031886869     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90252-9     Document Type: Article
Times cited : (17)

References (47)
  • 1
    • 0022459307 scopus 로고
    • Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals
    • Golay A, Chen YDI, Reaven GM: Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. J Clin Endocrinol Metab 62:1081-1088, 1986
    • (1986) J Clin Endocrinol Metab , vol.62 , pp. 1081-1088
    • Golay, A.1    Chen, Y.D.I.2    Reaven, G.M.3
  • 2
    • 0013772833 scopus 로고
    • Regulation of glucose uptake by muscle. IX. Effects of fatty acids and ketone bodies, and of alloxan diabetes and starvation, on pyruvate metabolism and on lactate/pyruvate and 1-glycerol 3-phosphate/dihydroxyacetone phosphate concentration ratios in rat heart and rat diaphragm muscles
    • Garland PB, Newsholme EA, Randle PJ: Regulation of glucose uptake by muscle. IX. Effects of fatty acids and ketone bodies, and of alloxan diabetes and starvation, on pyruvate metabolism and on lactate/pyruvate and 1-glycerol 3-phosphate/dihydroxyacetone phosphate concentration ratios in rat heart and rat diaphragm muscles. Biochem J 93:665-678, 1964
    • (1964) Biochem J , vol.93 , pp. 665-678
    • Garland, P.B.1    Newsholme, E.A.2    Randle, P.J.3
  • 3
    • 0026691368 scopus 로고
    • Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo
    • Nuutila P, Koivisto VA, Knuuti J, et al: Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 89:1767-1774, 1992
    • (1992) J Clin Invest , vol.89 , pp. 1767-1774
    • Nuutila, P.1    Koivisto, V.A.2    Knuuti, J.3
  • 4
    • 0025178653 scopus 로고
    • Operation of Randle's cycle in patients with NIDDM
    • Bevilacqua S, Buzzigoli G, Bonadonna R, et al: Operation of Randle's cycle in patients with NIDDM. Diabetes 39:383-389, 1990
    • (1990) Diabetes , vol.39 , pp. 383-389
    • Bevilacqua, S.1    Buzzigoli, G.2    Bonadonna, R.3
  • 5
    • 0021032715 scopus 로고
    • Effect of fatty acids on glucose production and utilization in man
    • Ferrannini E, Barrett EJ, Bevilacqua S, et al: Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747, 1983
    • (1983) J Clin Invest , vol.72 , pp. 1737-1747
    • Ferrannini, E.1    Barrett, E.J.2    Bevilacqua, S.3
  • 6
    • 0025775034 scopus 로고
    • Effects of lipid on basal carbohydrate metabolism in normal men
    • Boden G, Jadali F: Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes 40:686-692, 1991
    • (1991) Diabetes , vol.40 , pp. 686-692
    • Boden, G.1    Jadali, F.2
  • 7
    • 0027475061 scopus 로고
    • Contribution of muscle and liver to glucose-fatty acid cycle in humans
    • Saloranta C, Koivisto V, Widen E, et al: Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol 264:E599-E605, 1993
    • (1993) Am J Physiol , vol.264
    • Saloranta, C.1    Koivisto, V.2    Widen, E.3
  • 8
    • 0023237834 scopus 로고
    • Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects
    • Bevilacqua S, Bonadonna R, Buzzigoli G, et al: Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism 36:502-506, 1987
    • (1987) Metabolism , vol.36 , pp. 502-506
    • Bevilacqua, S.1    Bonadonna, R.2    Buzzigoli, G.3
  • 9
    • 0025949378 scopus 로고
    • Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin dependent diabetes mellitus
    • Vaag A, Skott P, Damsbo P, et al: Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin dependent diabetes mellitus. J Clin Invest 88:1282-1290, 1991
    • (1991) J Clin Invest , vol.88 , pp. 1282-1290
    • Vaag, A.1    Skott, P.2    Damsbo, P.3
  • 10
    • 0026644792 scopus 로고
    • Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects
    • Fulcher GR, Walker M, Catalano C, et al: Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes 41:1400-1408, 1992
    • (1992) Diabetes , vol.41 , pp. 1400-1408
    • Fulcher, G.R.1    Walker, M.2    Catalano, C.3
  • 11
    • 0027515569 scopus 로고
    • Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycaemia or total hepatic glucose production in NIDDM
    • Puhakainen I, Yki-Jarvinen H: Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycaemia or total hepatic glucose production in NIDDM. Diabetes 42:1694-1699, 1993
    • (1993) Diabetes , vol.42 , pp. 1694-1699
    • Puhakainen, I.1    Yki-Jarvinen, H.2
  • 12
    • 0026589396 scopus 로고
    • Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: Effects of acipimox
    • Fulcher GR, Walker M, Catalano C, et al: Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: Effects of acipimox. Clin Sci 82:565-571, 1992
    • (1992) Clin Sci , vol.82 , pp. 565-571
    • Fulcher, G.R.1    Walker, M.2    Catalano, C.3
  • 13
    • 0028998846 scopus 로고
    • The effect of 24-hour suppression of plasma nonesterified fatty acid levels on glucose and lipid metabolism in NIDDM
    • Davoren PM, Alberti KGMM: The effect of 24-hour suppression of plasma nonesterified fatty acid levels on glucose and lipid metabolism in NIDDM. Diabet Nutr Metab 8:17-23, 1995
    • (1995) Diabet Nutr Metab , vol.8 , pp. 17-23
    • Davoren, P.M.1    Alberti, K.G.M.M.2
  • 14
    • 0028203880 scopus 로고
    • Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in non-insulin dependent diabetes mellitus patients during a 3-day intensified treatment period
    • Worm D, Henriksen JE, Vaag A, et al: Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in non-insulin dependent diabetes mellitus patients during a 3-day intensified treatment period. J Clin Endocrinol Metab 78:717-721, 1994
    • (1994) J Clin Endocrinol Metab , vol.78 , pp. 717-721
    • Worm, D.1    Henriksen, J.E.2    Vaag, A.3
  • 15
    • 0027493805 scopus 로고
    • Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM
    • Saloranta C, Taskinen M, Widen E, et al: Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM. Diabetes 42:1559-1566, 1993
    • (1993) Diabetes , vol.42 , pp. 1559-1566
    • Saloranta, C.1    Taskinen, M.2    Widen, E.3
  • 16
    • 0000484708 scopus 로고
    • The effect of nicotinic acid in diabetes mellitus
    • Molnar GD, Berge KG, Rosevear JW, et al: The effect of nicotinic acid in diabetes mellitus. Metabolism 13:181-189, 1964
    • (1964) Metabolism , vol.13 , pp. 181-189
    • Molnar, G.D.1    Berge, K.G.2    Rosevear, J.W.3
  • 17
    • 0025148561 scopus 로고
    • Nicotinic acid therapy for treatment of dyslipidaemia in non-insulin dependent diabetes mellitus
    • Garg A, Grundy SM: Nicotinic acid therapy for treatment of dyslipidaemia in non-insulin dependent diabetes mellitus. JAMA 264:723-726, 1990
    • (1990) JAMA , vol.264 , pp. 723-726
    • Garg, A.1    Grundy, S.M.2
  • 18
    • 0019142367 scopus 로고
    • Inhibition of lipolysis by nicotinic acid and acipimox
    • Fucella L, Goldaniga G, Lovisolo P, et al: Inhibition of lipolysis by nicotinic acid and acipimox. Clin Pharmacol Ther 28:790-795, 1980
    • (1980) Clin Pharmacol Ther , vol.28 , pp. 790-795
    • Fucella, L.1    Goldaniga, G.2    Lovisolo, P.3
  • 19
    • 0026489172 scopus 로고
    • A double blind study of the effect of acipimox on serum lipids, blood glucose control and insulin action in non-obese patients with type 2 diabetes mellitus
    • Fulcher GR, Catalano C, Walker M, et al: A double blind study of the effect of acipimox on serum lipids, blood glucose control and insulin action in non-obese patients with type 2 diabetes mellitus. Diabet Med 9:908-914, 1992
    • (1992) Diabet Med , vol.9 , pp. 908-914
    • Fulcher, G.R.1    Catalano, C.2    Walker, M.3
  • 20
    • 0026473017 scopus 로고
    • Effects of prolonged acipimox treatment on glucose and lipid metabolism and on in vivo insulin sensitivity in patients with non-insulin dependent diabetes mellitus
    • Copenh
    • Vaag AA, Beck-Nielsen H: Effects of prolonged acipimox treatment on glucose and lipid metabolism and on in vivo insulin sensitivity in patients with non-insulin dependent diabetes mellitus. Acta Endocrinol (Copenh) 127:344-350, 1992
    • (1992) Acta Endocrinol , vol.127 , pp. 344-350
    • Vaag, A.A.1    Beck-Nielsen, H.2
  • 21
    • 0026694047 scopus 로고
    • The effect of acipimox in patients with type 2 diabetes and persistent hyperlipidaemia
    • Dean JD, McCarthy S, Betteridge DJ, et al: The effect of acipimox in patients with type 2 diabetes and persistent hyperlipidaemia. Diabet Med 9:611-615, 1992
    • (1992) Diabet Med , vol.9 , pp. 611-615
    • Dean, J.D.1    McCarthy, S.2    Betteridge, D.J.3
  • 22
    • 0027290746 scopus 로고
    • Improvement of lipoprotein lipid composition in type II diabetic patients with concomitant hyperlipoproteinaemia by acipimox treatment
    • Koev D, Cvrkalova A, Rybka J, et al: Improvement of lipoprotein lipid composition in type II diabetic patients with concomitant hyperlipoproteinaemia by acipimox treatment. Diabetes Care 16:1285-1290, 1993
    • (1993) Diabetes Care , vol.16 , pp. 1285-1290
    • Koev, D.1    Cvrkalova, A.2    Rybka, J.3
  • 23
    • 0027328873 scopus 로고
    • The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover
    • Seed M, O'Connor B, Perombelon N, et al: The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover. Atherosclerosis 101:61-68, 1993
    • (1993) Atherosclerosis , vol.101 , pp. 61-68
    • Seed, M.1    O'Connor, B.2    Perombelon, N.3
  • 24
    • 0024466520 scopus 로고
    • Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid
    • Carlson LA, Hamsten A, Asplund A: Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Int Med Res 226:271-276, 1989
    • (1989) J Int Med Res , vol.226 , pp. 271-276
    • Carlson, L.A.1    Hamsten, A.2    Asplund, A.3
  • 25
    • 0017670714 scopus 로고
    • Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity
    • Harano Y, Ohgaku S, Hidaka H, et al: Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. J Clin Endocrinol Metab 45:1124-1127, 1977
    • (1977) J Clin Endocrinol Metab , vol.45 , pp. 1124-1127
    • Harano, Y.1    Ohgaku, S.2    Hidaka, H.3
  • 26
    • 0021800286 scopus 로고
    • A comparison of 3 methods for assessing insulin sensitivity in subjects with normal and abnormal glucose tolerance
    • Heine RJ, Home PD, Poncher M, et al: A comparison of 3 methods for assessing insulin sensitivity in subjects with normal and abnormal glucose tolerance. Diabetes Res 2:113-120, 1985
    • (1985) Diabetes Res , vol.2 , pp. 113-120
    • Heine, R.J.1    Home, P.D.2    Poncher, M.3
  • 27
    • 0021684350 scopus 로고
    • Automated enzymatic determination of plasma free fatty acids by centrifugal analysis
    • Knox DP, Jones DG: Automated enzymatic determination of plasma free fatty acids by centrifugal analysis. J Automated Chem 6:152-154, 1984
    • (1984) J Automated Chem , vol.6 , pp. 152-154
    • Knox, D.P.1    Jones, D.G.2
  • 28
    • 0025633126 scopus 로고
    • Optimized methods to measure acetoacetate, 3-hydroxybutyrate, glycerol, alanine, pyruvate, lactate and glucose in human blood using a centrifugal analyser with a fluorimetric attachment
    • Stappenbeck R, Hodson AW, Skillen AW, et al: Optimized methods to measure acetoacetate, 3-hydroxybutyrate, glycerol, alanine, pyruvate, lactate and glucose in human blood using a centrifugal analyser with a fluorimetric attachment. J Automatic Chem 12:213-220, 1990
    • (1990) J Automatic Chem , vol.12 , pp. 213-220
    • Stappenbeck, R.1    Hodson, A.W.2    Skillen, A.W.3
  • 29
    • 0026527767 scopus 로고
    • Summarising laboratory data with difference ranges in multicenter clinical trials
    • Chuang-Stein C: Summarising laboratory data with difference ranges in multicenter clinical trials. Drug Inform J 26:77-84, 1992
    • (1992) Drug Inform J , vol.26 , pp. 77-84
    • Chuang-Stein, C.1
  • 30
    • 0023840497 scopus 로고
    • Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridaemia
    • Taskinen M, Nikkila EA: Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridaemia. Atherosclerosis 69:249-255, 1988
    • (1988) Atherosclerosis , vol.69 , pp. 249-255
    • Taskinen, M.1    Nikkila, E.A.2
  • 31
    • 0022898291 scopus 로고
    • Acipimox in the treatment of patients with hyperlipidaemia: A double blind trial
    • Ball MJ, Vella M, Reckless JPD, et al: Acipimox in the treatment of patients with hyperlipidaemia: A double blind trial. Eur J Clin Pharmacol 31:201-204, 1986
    • (1986) Eur J Clin Pharmacol , vol.31 , pp. 201-204
    • Ball, M.J.1    Vella, M.2    Reckless, J.P.D.3
  • 32
    • 0021997064 scopus 로고
    • Effects of acipimox, a nicotinic acid derivative, on lipolysis in human adipose tissue and on cholesterol synthesis in human jejunal mucosa
    • Stirling C, McAleer M, Reckless JPD, et al: Effects of acipimox, a nicotinic acid derivative, on lipolysis in human adipose tissue and on cholesterol synthesis in human jejunal mucosa. Clin Sci 68:83-88, 1985
    • (1985) Clin Sci , vol.68 , pp. 83-88
    • Stirling, C.1    McAleer, M.2    Reckless, J.P.D.3
  • 33
    • 0030603999 scopus 로고    scopus 로고
    • Effects of gemfibrozil on very-low-density lipoprotein composition and low-density lipoprotein size in patients with hypertriglyceridemia or combined hyperlipidemia
    • Yang CY, Gu ZW, Xie YH, et al: Effects of gemfibrozil on very-low-density lipoprotein composition and low-density lipoprotein size in patients with hypertriglyceridemia or combined hyperlipidemia. Atherosclerosis 126:105-116, 1996
    • (1996) Atherosclerosis , vol.126 , pp. 105-116
    • Yang, C.Y.1    Gu, Z.W.2    Xie, Y.H.3
  • 34
    • 0029022637 scopus 로고
    • Effect of simvastatin on Lp(a) concentrations
    • Haffner S, Orchard T, Stein E, et al: Effect of simvastatin on Lp(a) concentrations. Clin Cardiol 18:261-267, 1995
    • (1995) Clin Cardiol , vol.18 , pp. 261-267
    • Haffner, S.1    Orchard, T.2    Stein, E.3
  • 35
    • 0026660451 scopus 로고
    • Changes in Lp(a) lipoprotein levels during the treatment of hypercholesterolaemia with simvastatin
    • Slunga L, Johnson O, Dahlen GH: Changes in Lp(a) lipoprotein levels during the treatment of hypercholesterolaemia with simvastatin. Eur J Clin Pharmacol 43:369-373, 1992
    • (1992) Eur J Clin Pharmacol , vol.43 , pp. 369-373
    • Slunga, L.1    Johnson, O.2    Dahlen, G.H.3
  • 36
    • 0024392514 scopus 로고
    • Glucose and free fatty acid metabolism in non-insulin dependent diabetes mellitus
    • Groop LC, Bonadonna RC, Delprato S, et al: Glucose and free fatty acid metabolism in non-insulin dependent diabetes mellitus. J Clin Invest 84:205-213, 1989
    • (1989) J Clin Invest , vol.84 , pp. 205-213
    • Groop, L.C.1    Bonadonna, R.C.2    Delprato, S.3
  • 37
    • 0028357199 scopus 로고
    • Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients
    • Hoffman J, Spengler M: Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. Diabetes Care 17:561-566, 1994
    • (1994) Diabetes Care , vol.17 , pp. 561-566
    • Hoffman, J.1    Spengler, M.2
  • 38
    • 0029064970 scopus 로고
    • Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus
    • Coniff RF, Shapiro JA, Seaton TB, et al: Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus. Am J Med 98:443-451, 1995
    • (1995) Am J Med , vol.98 , pp. 443-451
    • Coniff, R.F.1    Shapiro, J.A.2    Seaton, T.B.3
  • 39
    • 0029099086 scopus 로고
    • Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus
    • DeFronzo RA, Goodman AM, and the Multicenter Metformin Study Group: Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333:541-549, 1995
    • (1995) N Engl J Med , vol.333 , pp. 541-549
    • DeFronzo, R.A.1    Goodman, A.M.2
  • 40
    • 0027326414 scopus 로고
    • Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea treated patients with NIDDM
    • Wolffenbuttel BH, Nijst L, Sels JP, et al: Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea treated patients with NIDDM. Eur J Clin Pharmacol 45:113-116, 1993
    • (1993) Eur J Clin Pharmacol , vol.45 , pp. 113-116
    • Wolffenbuttel, B.H.1    Nijst, L.2    Sels, J.P.3
  • 41
    • 13144288375 scopus 로고
    • Clinical profile of glimeperide
    • Draeger E: Clinical profile of glimeperide. Diabetes Res Clin Pract 28:8139-8146, 1995 (suppl)
    • (1995) Diabetes Res Clin Pract , vol.28 , Issue.SUPPL. , pp. 8139-8146
    • Draeger, E.1
  • 42
    • 0021691098 scopus 로고
    • Relationships between insulin secretion, insulin action and fasting plasma glucose concentration in non-diabetic and non-insulin dependent diabetic subjects
    • Bogardus C, Lillioja S, Howard BV, et al: Relationships between insulin secretion, insulin action and fasting plasma glucose concentration in non-diabetic and non-insulin dependent diabetic subjects. J Clin Invest 74:1238-1246, 1984
    • (1984) J Clin Invest , vol.74 , pp. 1238-1246
    • Bogardus, C.1    Lillioja, S.2    Howard, B.V.3
  • 43
    • 0023189066 scopus 로고
    • Relationships between plasma free fatty acid concentration, endogenous glucose production, and fasting hyperglycaemia in normal and non-insulin-dependent diabetic individuals
    • Golay A, Swislocki ALM, Chen YI, et al: Relationships between plasma free fatty acid concentration, endogenous glucose production, and fasting hyperglycaemia in normal and non-insulin-dependent diabetic individuals. Metabolism 36:692-696, 1987
    • (1987) Metabolism , vol.36 , pp. 692-696
    • Golay, A.1    Swislocki, A.L.M.2    Chen, Y.I.3
  • 44
    • 0027509296 scopus 로고
    • Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate
    • Fulcher GR, Walker M, Farrer M, et al: Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate. Metabolism 42:308-314, 1993
    • (1993) Metabolism , vol.42 , pp. 308-314
    • Fulcher, G.R.1    Walker, M.2    Farrer, M.3
  • 45
    • 0029042116 scopus 로고
    • The effect of acipimox on glucose disposal in non-insulin dependent diabetes is dependent on the lowering of nonesterified fatty acid levels
    • Davoren PM, Motala A, Alberti KGMM: The effect of acipimox on glucose disposal in non-insulin dependent diabetes is dependent on the lowering of nonesterified fatty acid levels. Diabet Nutr Metab 8:99-104, 1995
    • (1995) Diabet Nutr Metab , vol.8 , pp. 99-104
    • Davoren, P.M.1    Motala, A.2    Alberti, K.G.M.M.3
  • 46
    • 0019370336 scopus 로고
    • Pharmacological profile of a new anti-lipolytic agent: 5-Methyl-pyrazine-2-carboxylic acid 4-oxide (acipimox). I. Mechanism of action
    • Lovisolo PP, Briatico-Vangosa G, Orsini G, et al: Pharmacological profile of a new anti-lipolytic agent: 5-Methyl-pyrazine-2-carboxylic acid 4-oxide (acipimox). I. Mechanism of action. Pharmacol Res Commun 13:151-161, 1981
    • (1981) Pharmacol Res Commun , vol.13 , pp. 151-161
    • Lovisolo, P.P.1    Briatico-Vangosa, G.2    Orsini, G.3
  • 47
    • 0030031015 scopus 로고    scopus 로고
    • Mechanism of anti-lipolytic action of acipimox in isolated rat adipocytes
    • Christie AW, McCormick DKT, Emmison N, et al: Mechanism of anti-lipolytic action of acipimox in isolated rat adipocytes. Diabetologia 39:45-53, 1996
    • (1996) Diabetologia , vol.39 , pp. 45-53
    • Christie, A.W.1    McCormick, D.K.T.2    Emmison, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.